@Dutchy 

Last reply

Dutchy

Ocrevus now approved by NICE for PPMS

https://www.mstrust.org.uk/news/good-news-nice-approves-ocrevus-ocrelizumab-primary-progressive-ms Today's announcement. The MS Trust is delighted that Ocrevus (ocrelizumab) has been approved by NICE for NHS treatment of early, inflammatory primary progressive MS. NICE has approved Ocrevus for people with primary progressive MS if they: have had symptoms of primary progressive MS for 15 years or less and are able to walk 20 metres or more, with or without walking aids (up to EDSS 6.5) and have evidence of MS activity on MRI scans.
@Cathie16

As someone who has just been diagnosed with PPMS I'm rather encouraged by this. Any views on its effectiveness would be appreciated!

@Vixen

Hi @cathie16, scroll down for earlier posts today, especially from @dominics